ArticleGenetics and molecular biology2026
Nutriepigenetics and nutriepigenomics: Exploring the interactions between nutrition, epigenetics, and epigenomics in the pathogenesis of noncommunicable diseases.
Article in Genetics and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The complex interaction between nutrition, epigenetics, and epigenomics in non-communicable diseases (NCDs) such as cardiovascular diseases, obesity, type 2 diabetes mellitus (T2DM), and cancer highlights the crucial role of nutrition as an environmental factor influencing gene expression through epigenetic mechanisms such as DNA methylation, histone modifications, and regulation through non-coding RNAs (ncRNAs). The aim of this review is to explore the importance of interactions between nutrition-epigenetics interactions in the pathogenesis of NCDs and in the development of personalized prevention and treatment strategies. These nutriepigenetic and nutriepigenomic processes are fundamental for understanding the underlying molecular mechanisms of NCDs development. Diet plays a central role in modulating gene expression, and studies indicate how nutrients and bioactive compounds in food can directly affect epigenetic patterns, influencing the risk and progression of NCDs. For example, dietary effects on DNA methylation and miRNA expression have been associated with changes in susceptibility to cardiovascular diseases, obesity, and T2DM. Additionally, phytochemicals such as curcumin, genistein, quercetin, equol, among others found in certain foods can epigenetically modulate gene expression, playing a role in cancer prevention. The complexity of nutriepigenetic and nutriepigenomic systems highlights the need for a personalized approach to disease prevention and treatment. Understanding how diet influences epigenetic patterns can provide crucial insights for the development of more targeted and effective therapeutic strategies, ultimately underscoring the growing translational value of nutriepigenetics and nutriepigenomics in advancing precision medicine and informing population-level interventions, reinforcing their clinical, preventive, and societal impact in mitigating the burden of NCDs.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.